Switching From Semaglutide to Tirzepatide: When It Makes Sense (and How Doctors Do It)

Somewhere around month four to six, a subset of semaglutide patients hits a genuine plateau: the scale freezes for a month or more despite good adherence. The internet's answer is always the same: switch to Mounjaro. Sometimes that is right. Tirzepatide's dual GIP and GLP-1 action did beat semaglutide head-to-head in the SURMOUNT-5 trial. But a switch costs real money and resets your side-effect adjustment, so it should be the third option, not the first.

First, confirm it is actually a plateau

• Four or more weeks with no scale movement and no change in waist measurement. Two flat weeks is noise, not a plateau.
• You are at a genuinely therapeutic semaglutide dose (1.0 mg or above), not stuck at a starter dose.
• Adherence is real: no missed doses, no cold-chain failures with the pen, calories have not quietly crept up. Track a normal week honestly before concluding anything.
• You have already lost 10% or more of starting weight. Bodies defend a lower weight harder; slowing after 10% is physiology, not failure.

The cheaper fixes to try before switching

1. 1Escalate semaglutide first. If you plateau at 1.0 mg, the 1.7 and 2.4 mg doses exist precisely for this, and cost far less than moving to branded tirzepatide.
2. 2Audit protein and strength training. Losing muscle lowers your metabolic rate and stalls fat loss. 1.2 to 1.6 g protein per kg of target weight and two resistance sessions a week reopen many plateaus.
3. 3Fix sleep and check thyroid. Under 6 hours of sleep and untreated hypothyroidism both quietly stall weight loss and are worth ruling out with your doctor.

When the switch is justified

A doctor will typically consider tirzepatide when you have plateaued for 6 to 8 weeks at maximum tolerated semaglutide, when semaglutide side effects were limiting before you reached an effective dose, or when you started with a very high BMI where tirzepatide's larger average effect meaningfully changes the outcome. It is also considered when significant insulin resistance or prediabetes persists, since the GIP action adds metabolic benefit.

How the crossover actually works

There is no official conversion table between the two medicines, so doctors switch conservatively. The usual pattern: take your final semaglutide dose, wait one full week (the normal dose interval), then begin tirzepatide, typically at 2.5 or 5 mg depending on how high your semaglutide dose was and how you tolerated it. Expect a few transition weeks where appetite suppression dips or gut symptoms briefly return. Do not attempt this crossover yourself; the starting rung decision genuinely needs a clinician.